TargEDys' Series A - III Round

TargEDys raised a round of funding on April 11, 2017. Investors include Zaluvida.

TargEDys is dedicated to the modulation of appetite and develops functional food, medical food and pharmaceutical products to harness the microbiome's ability to regulate appetite and thus maintain or…

Articles about TargEDys' Series A - III Round: